We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Collaboration to Produce New High-Throughput Mass Spectrometry System

By LabMedica International staff writers
Posted on 20 Jun 2011
Two major developers of mass spectrometry instruments are collaborating to produce a new analytical system to cater to the requirements of researchers and analysts demanding dedicated hardware for high-throughput pharmaceutical applications, forensic toxicology, and food safety testing.

The two companies, AB SCIEX (Foster City, CA, USA) and Phytronix Technologies (Quebec City, Canada) are working to integrate Phytronix's LDTD (Laser Diode Thermal Desorption) Ion source with the AB SCIEX TripleTOF 5600 Mass Spectrometry System.

The AB SCIEX TripleTOF 5600 System already offers a fast and sensitive high-resolution mass spectrometer for high-performance qualitative and quantitative analysis. More...
This technology will be complemented by Phytronix's LDTD Ion Source, which is reputed to be the fastest high throughput solution on the market. This innovative design is based on a shotgun approach where the sample is introduced in the mass spectrometer by a rapid laser thermal desorption process and is ionized by an atmospheric pressure chemical reactions (LDTD-APCI).

"The combination of LDTD and the AB SCIEX Triple TOF 5600 System provides an unmatchable tool for drug discovery as well as clinical research, forensics, and food safety analysis. Our LDTD Ion Source introduces a sample by a rapid laser thermal desorption process into an AB SCIEX MS/MS, ionizing it via atmospheric pressure chemical ionization without mobile phase. This "shotgun" approach, coupled with the TripleTOF system, offers a full MS analysis with the exact mass in less than four seconds," said Jean Lacoursière, president of Phytronix Technologies.

Dave Hicks, a vice president at AB SCIEX, said, "AB SCIEX is committed to the high-throughput market, and with the AB SCIEX TripleTOF 5600 System setting a new standard in innovation, we are confident that we can push the limits in this area better than anyone else. Several of our customers are already working with LDTD-MS/MS, so this integration with Phytronix is a natural step forward in our strategy to broaden the options for scientists and lab analysts utilizing high-throughput workflows."

Related Links:
AB SCIEX
Phytronix Technologies


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.